AMIDE INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4a, R4b, R4c, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, R9 and R10 are described herein, or pharmaceutically acceptable salts, solvates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydro...

Full description

Saved in:
Bibliographic Details
Main Authors GUILFORD, WILLIAM, CHEN, MING, LIGHT, DAVID, DAVEY, DAVID, KHIM, SEOCK-KYU, YE, HONG, VOGEL, DAVID, YE, BIN, KIRKLAND, THOMAS, KOCHANNY, MONICA, CLARET, EMMANUEL, CLEVE, ARWED, LIANG, AMY, PARKINSON, JOHN, WEI, GUO, PING
Format Patent
LanguageEnglish
French
Published 27.08.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4a, R4b, R4c, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, R9 and R10 are described herein, or pharmaceutically acceptable salts, solvates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and which are therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of using and preparing the compounds of the invention are also disclosed. La présente invention concerne des composés de formule (I) : dans laquelle r, q, R, R2, R3, R4a, R4b, R4c, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, R9 et R10 sont tels que décrits ici, ou des sels, des solvates, des polymorphes, des ions ammonium, des N-oxydes ou des promédicaments pharmaceutiquement acceptables de ces composés. Lesdits composés sont des inhibiteurs de la leucotriène A4 hydrolase et ils sont donc utilisables pour le traitement des inflammations. L'invention concerne également des compositions pharmaceutiques comprenant les composés de l'invention ainsi que des procédés de préparation et d'utilisation des composés de l'invention.
Bibliography:Application Number: WO2006US48849